KRYSTAL RAFENSTEIN: Open Payments
NPI 1336798685 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 58 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $175 |
| ANI Pharmaceuticals, Inc. | 6 | $174 |
| Teva Pharmaceuticals USA, Inc. | 5 | $121 |
| Lundbeck LLC | 4 | $104 |
| Axsome Therapeutics, Inc. | 5 | $99 |
| ABBVIE INC. | 5 | $94 |
| Tris Pharma Inc | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Lilly USA, LLC | 3 | $51 |
Products named: PURIFIED CORTROPHIN GEL, REXULTI, AUSTEDO XR, Auvelity, Wegovy, Dyanavel XR, VRAYLAR, MOUNJARO.
Industry payments across WI — which companies pay providers there.
